WebGuangdong Newopp Biopharmaceuticals Co., Ltd. 0 Active Cases 0 Inactive Cases 0 Patents in Litigation 0 Petitions 0 Related Entities Litigations for Guangdong Newopp Biopharmaceuticals Co., Ltd. Patent Information for Guangdong Newopp Biopharmaceuticals Co., Ltd. Petitions for Guangdong Newopp Biopharmaceuticals … WebGuangdong Newopp Biopharmaceuticals Co., Ltd. Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2024-06-24 Filing date 2024-06-23 Publication date 2024-12-30 Priority claimed from US202462921513P external ...
Guangdong Newopp Biopharmaceuticals presents new …
WebGuangdong Newopp Biopharmaceuticals Co Ltd Original Assignee Guangdong Newopp Biopharmaceuticals Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2024-02-06 Filing date 2024-02-05 Publication date ... Web企查查为您提供NewOpp Holdings Limited的最新工商信息、公司简介、公司地址、电话号码、招聘信息、信用信息、财务信息、法律诉讼等多维度详细信息查询,让您对NewOpp Holdings Limited能够做到全面的了解! state of alaska ladies first
EP3917936A4 - Acides alkylboroniques en tant qu
WebSep 20, 2024 · 地址: 广州市黄埔区开源大道188号二栋202房 附近企业 企查查行业: 企业规模: 员工人数: 简介:广东新契生物医药科技有限公司是抗肿瘤创新药物研发企业,核心团队成员具有领导研发多款小分子创新药物并实现上市的成功经验。 财产线索 线索 94 预估价值 产品信息: 新契生物 最新融资轮次 - 股权穿透图 挖掘深层股权结构 企业图谱 企业 … WebApr 4, 2024 · Mechanistically, tumor-derived PGE2 acts on EP2 and EP4 in immune cells (e.g., NK cells and dendritic cells) and elicits immunosuppression in TME 1,2. … Web[16]Current Patent Assignee: GUANGDONG NEWOPP BIOPHARMACEUTICALS - WO2024/120296, 2024, A1 Location in patent: Page/Page column 69 [17]Current Patent Assignee: GUANGDONG NEWOPP BIOPHARMACEUTICALS - WO2024/160707, 2024, A1 Location in patent: Page/Page column 103. 3 [ 95034-05-2 ] [ 1148-11-4 ] state of alaska las system